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Abstract
Estimates from various disease-specific registries suggest that chronic inflammatory and fibrotic disorders affect
a large proportion of the world’s population, yet therapies for these conditions are largely ineffective. Recent
advances in our collective understanding of mechanisms underlying both physiological and pathological repair of
tissue injury are informing new clinical approaches to deal with various human inflammatory and fibrotic diseases.
This 2013 Annual Review Issue of The Journal of Pathology offers an up-to-date glimpse of ongoing research in
the fields of inflammation, wound healing, and tissue fibrosis, and highlights novel pathways and mechanisms
that may be exploited to provide newer, more effective treatments to patients worldwide suffering from these
conditions.
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Ever since the initial descriptions of the cardinal char-
acteristics of inflammation – rubor , dolor , calor , and
tumour – by the first-century Roman medical writer
Aulus Cornelius Celsus [1], physicians and scientists
have attempted to unravel the mysteries behind the
human body’s response to injury. Despite the fact that
the basic steps underpinning the highly orchestrated
and complex manner in which the body attempts to
heal injuries (and it bears mentioning here that ‘injury’
is a term not limited solely to trauma, but also to
the broader concept of disturbances in normal home-
ostasis due to infection, metabolic insults, degenerative
or ageing disorders, malignant transformation ,and the
like) are well known, we are still ignorant in key areas
that may allow us to understand the fine-tuning of this
response; hence, there is a strong need to periodically
reflect on how far we’ve come in our knowledge and
identify important gaps in evidence that require ‘fill-
ing in’. For example, our abilities to predict when
a wound will heal in a fashion that restores normal
tissue homeostasis or will progress to a fibrotic, archi-
tecturally compromised tissue are limited. We do not
yet fully comprehend why some fetal wounds heal
without evidence of scarring, whereas others scar sim-
ilarly to postnatal wounds [2]. Although tissue fibrosis
clearly occurs following the resolution of inflamma-
tion, we do not yet understand why certain human
diseases appear to result in scarring without significant
antecedent inflammation [3]. Collectively, we appre-
ciate that many malignancies share similarities with
chronic inflammatory wounds [4] but it is only recently
that we have begun to truly understand the role of
host inflammatory and reparative cells in cancer devel-
opment and progression. Similarly, we are becoming
increasingly aware of the influence of non-cellular tis-
sue constituents (extracellular matrix, soluble medi-
ators, etc.) on tissue repair and homeostasis. These
issues are not purely academic; recent estimates sug-
gest that chronic inflammatory and fibrotic disorders
are responsible for $142 billion in annual United States
healthcare costs alone [5–7]. As a means to begin
addressing some of these deficiencies (and many oth-
ers) in knowledge, the 2013 Annual Review Issue on
Inflammation, Wound Repair, and Fibrosis was born.
The highly interconnected nature of science creates
significant artificiality in identifying discrete topics
around which discussions of both physiological and
pathological tissue repair revolve. By necessity, how-
ever, science is often performed in easily digestible
‘bite-sized chunks’ that allow us to answer specific
questions using reductionist approaches and it is
through this type of investigation that we hope to
better understand the processes that define a physi-
ological response to injury and the myriad ways in
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which it can go awry. Perhaps the simplest (and most
conventional) way to approach this topic is, as the title
suggests, to divide the discussion among the concepts
of inflammation (comprising the influx of inflamma-
tory cells and mediators that orchestrate the initial
response to tissue injury), wound healing (dealing with
the physiological steps necessary to restore normal
tissue structure and function), and fibrosis (concerning
the pathophysiological response following injury that
leads to ineffective and/or inappropriate tissue repair).
To do so, however, invites the acknowledgement that
the distinction between physiology and pathology is
blurry, defined by matters of degree; enough inflam-
mation and repair can heal a wound and restore tissue
integrity and function, whereas excessive inflammation
and/or repair (even if accomplished by physiological
mechanisms) may lead to tissue dysfunction. Thus,
while inflammation and fibrosis may occur due to
abnormal processes, they may also be construed as
‘too much of a good thing’. In this year’s Annual
Review Issue, we begin to tackle some of these issues,
all the while recognizing that further work in these
arenas will be necessary to advance our knowledge
for purposes of appreciating the true underpinnings of
tissue homeostasis, injury repair, and fibrosis.
Recognition of tissue injury and recruitment of
inflammatory cells to sites of tissue injury is a fun-
damental aspect of cell biology and may occur via a
number of very different mechanisms. For example,
the innate immune system senses the presence of inju-
rious stimuli through pattern recognition receptors;
these receptors are critically attuned to the presence
of exogenous pathogen-associated molecular patterns
(PAMPs) and endogenous damage-associated molecu-
lar patterns (DAMPs), which largely comprise extra-
cellular matrix (ECM) proteins, cell stress-induced
proteins, and released immunomodulators [8]. Subse-
quently, recruitment and homing of inflammatory cells
(primarily via chemokines and other cytokines) begins
the process of controlling the injury and healing the
tissue damage. Recent data suggest that the NLRP3
inflammasome, a key cellular sensor that results in
the generation of an inflammatory response, is a crit-
ical component of the initial response to injury [9].
Moreover, tight regulation of chemokine expression
and maintenance within tissues also directly influences
the degree of inflammation, and evidence is emerging
that an ‘atypical’ chemokine receptor (D6) plays an
important role in this crucial aspect of tissue injury and
inflammation [10]. Simultaneously (or shortly there-
after), mononuclear cell infiltration, to clear cellu-
lar debris and begin remodelling the injured tissues,
occurs. It is noteworthy that all mononuclear inflam-
mation is not the same; macrophage responses within
injured tissues are quite plastic and are driven by the
microenvironment, usually in preparation for resolving
the inflammatory response via M2 polarization [11].
In the setting of chronic inflammation due to parasitic
infection, the balance between M1 and M2 polariza-
tion is similarly accentuated and perhaps responsible
for resolution of inflammation or the lack thereof [12].
It is also becoming clearer that fibroblasts, structural
cells that participate in homeostatic regulation of tissue
integrity, can be ‘co-opted’ by pathological processes
such as malignancies to induce tissue injury and inflam-
mation [13]. Whether this accumulation of fibroblasts
in chronic malignant inflammation or fibrosis occurs
due to enhanced proliferation or defects in autophagy
(or both) is unclear, although evidence suggests that
the balance between the two may be askew [14].
Several intracellular signalling pathways are emerg-
ing as potentially important for wound injury and
repair, affecting cell fate and phenotype. To be sure,
these pathways are also usually of significant import
in health, where they maintain homeostasis and normal
organ function. One such pathway, the Wnt/β-catenin
pathway, has received a great deal of attention in this
regard. Developmentally, Wnt9b and Wnt4 (ligands
that activate the Wnt pathway) in the kidney pro-
vide impetus for mesenchymal-to-epithelial transition
resulting in nephrogenesis. In damaged renal tissues,
this pathway is re-activated as the kidney attempts
to regenerate into functional tissue; however, in dis-
orders of chronic injury and fibrosis, the regulation
of Wnt may be dysregulated [15]. Similarly, reactive
oxygen and nitrogen species, long known to induce
tissue injury and contribute to disease pathogenesis,
are also critical messengers of damage within tis-
sues. Mechanisms to limit free radical generation or
to scavenge/inhibit inappropriately-produced free rad-
icals are important for cellular homeostasis, but evi-
dence suggests that in the diabetic myocardium these
adaptive measures may be abnormal, thereby promot-
ing tissue injury [16]. Likewise, nitric oxide signalling
and its attendant effects on vascular tone may play a
role in wound healing, and experimental data suggest
that dimethylarginine dimethylaminohydrolases influ-
ence wound healing in the lung to induce fibrosis [17].
Finally, recent attention has focused not only on pro-
inflammatory mechanisms and mediators, but also on
endogenous anti-inflammatory mechanisms that limit
tissue inflammation and promote wound healing [18].
It warrants remembering that exuberant overexpression
of anti-inflammatory molecules (eg TGF-β) promotes
fibrosis and that limiting inflammation in disease may
result in unintended consequences. Thus, the crux of
research in this arena really should focus on how to
resolve chronic inflammation without promoting tissue
fibrosis – the Holy Grail.
Genetic and genomic variability likely accounts for
some of the differences between individuals when it
comes to the development of fibrosis or chronic inflam-
mation, and both heritable and acquired traits have
been implicated in wound healing and fibrogenesis.
Epigenetic phenomena, including histone modifica-
tions and promoter hypermethylation, are known to
influence gene expression in fibroblasts, macrophages,
and other wound-healing cells. Moreover, evidence
suggests that strategies to reverse these acquired DNA
changes may have therapeutic benefit in fibrosis [19].
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Along the same lines, investigation into a class of
non-coding RNAs termed microRNAs (miRNAs) has
only recently begun to elucidate their effects on gene
expression. To that end, more than 1000 miRNA
transcripts are known to be encoded by the human
genome, and each one often controls a portfolio of
genes. Evidence suggests that certain miRNAs may be
instrumental in driving fibrogenesis, especially in light
of miRNAs that affect TGF-β expression [20]. Within
the nucleus, transcription factors also play a key role
in driving cell phenotype and responses to external
stimuli. While it is not uncommon for transcription
factors to play multiple roles within cells, recent data
have identified the early growth response-1 (Egr-1)
transcription factor and its binding protein Nab2 in
driving pathological fibrosis [21].
Increasingly, researchers in the fields of inflamma-
tion, wound healing, and fibrosis are recognizing that
extracellular influences exist to alter the rate and effi-
cacy of wound healing. For instance, it is becoming
widely recognized that the ECM is much more than just
scaffolding upon and in which cells reside, but rather
a complex admixture of proteins that provide spatial
and temporal context for cells. The importance of the
ECM in directing such cellular functions is reflected in
the recent coining of the term ‘matrisome’ to include
ECM and ECM-related molecules that together direct
cell function [22]. In fibrotic disorders, the ECM is
typically produced by myofibroblasts (highly synthetic
fibroblast-like cells with contractile capabilities) and
may contribute significantly to tissue remodelling [23].
Similarly, empirical observations suggest that advanced
age may have profound influences on inflammation and
wound healing. As alluded to previously, fetal wounds
are capable of healing without scar formation, although
little is known about attendant mechanisms for this
observation. In the human lung, ageing predisposes to
fibrogenesis and this is explored in some detail [24].
Finally, emerging data suggest that the host itself is
not the only source of influence on inflammation and
wound healing. As discussed herein, the microbiome –
the entire collection of organisms (bacterial, viral, fun-
gal, etc.) inhabiting a host – also likely has a significant
influence in host wound healing and fibrosis [25].
No scientific review on inflammation, wound
healing, and fibrosis would be complete without
providing examples of how our new-found knowledge
will prove meaningful for patient care. With that
in mind, Shechter and Schwartz explore the role of
macrophages in central nervous system pathology
(including psychiatric disorders) first by reviewing
evidence that heterogeneity of cell sub-populations
reveals destructive forces but also regenerative ones
and then by positing how scientists may one day be
able to harness salutary effects while inhibiting detri-
mental ones for purposes of therapeutic intervention
in these difficult-to-treat disorders [26]. Similarly,
Elnakish et al . critically appraise the role of stem cells
of various origins in the development of experimental
cardiac fibrosis and explore the possibility of cell-based
therapy for patients with these disorders [27].
We have clearly come a long way since the four
cardinal features of inflammation were defined. Yet
we still have a way to go before we achieve clarity
in understanding all the pieces that drive a successful
inflammatory and wound healing response or promote
a pathological fibrotic one. We hope that the articles
in this Review Issue will enhance the reader’s under-
standing, but also inspire further investigation that will
ultimately improve the lives of our collective patients.
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